(Q45244529)

English

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients (English)

1 reference

Europe PubMed Central

11 December 2017

type 2 diabetes

0 references

0 references

fatty liver disease

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

3

object named as

Masato Yoneda

1 reference

Europe PubMed Central

11 December 2017

Kazuaki Chayama

19

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

11 December 2017

10

object named as

Hiroshi Aikata

1 reference

Europe PubMed Central

11 December 2017

2

object named as

Hideyuki Hyogo

1 reference

Europe PubMed Central

11 December 2017

Takashi Nakahara

1

object named as

Takashi Nakahara

1 reference

Europe PubMed Central

11 December 2017

author name string

Yoshio Sumida

4

1 reference

Europe PubMed Central

11 December 2017

Yuichiro Eguchi

5

1 reference

Europe PubMed Central

11 December 2017

Hideki Fujii

6

1 reference

Europe PubMed Central

11 December 2017

Masafumi Ono

7

1 reference

Europe PubMed Central

11 December 2017

Takumi Kawaguchi

8

1 reference

Europe PubMed Central

11 December 2017

Kento Imajo

9

1 reference

Europe PubMed Central

11 December 2017

Saiyu Tanaka

11

1 reference

Europe PubMed Central

11 December 2017

Kazuyuki Kanemasa

12

1 reference

Europe PubMed Central

11 December 2017

Kazuma Fujimoto

13

1 reference

Europe PubMed Central

11 December 2017

Keizo Anzai

14

1 reference

Europe PubMed Central

11 December 2017

Toshiji Saibara

15

1 reference

Europe PubMed Central

11 December 2017

Michio Sata

16

1 reference

Europe PubMed Central

11 December 2017

Atushi Nakajima

17

1 reference

Europe PubMed Central

11 December 2017

Yoshito Itoh

18

1 reference

Europe PubMed Central

11 December 2017

Takeshi Okanoue

20

1 reference

Europe PubMed Central

11 December 2017

Japan Study Group of Nonalcoholic Fatty Liver Disease

21

1 reference

Europe PubMed Central

11 December 2017

publication date

26 November 2013

1 reference

Europe PubMed Central

11 December 2017

Journal of Gastroenterology

1 reference

Europe PubMed Central

11 December 2017

49

1 reference

Europe PubMed Central

11 December 2017

11

1 reference

Europe PubMed Central

11 December 2017

1477-1484

1 reference

Europe PubMed Central

11 December 2017

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic fatty liver disease as a complication of insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Glucose tolerance and diabetes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Glucose and insulin metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0911-1

21 January 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet count for predicting fibrosis in nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of nonalcoholic fatty liver: a follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24277052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-013-0911-1

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45244529&oldid=2071246892"